1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. INTRA-CELLULAR THERAPIES INC

Intra-Cellular Therapies Inc

XNAS: ITCI

Momentum Trap

Watchlist

Portfolio

Share


Insider Trading disclosures for Intra-Cellular Therapies Inc

The latest disclosure was made by Sharon Mates in Intra-Cellular Therapies Inc where a trade of 190,000 Common Stock done was reported to US exchanges on March 26, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Sharon Mates Director, Chairman and CEO Gift of securities by or to the insider at price $ 0.00 per share. 26 Mar 2025 190,000 945,235 (1%) 0% 0 Common Stock
Sharon Mates Director, Chairman and CEO Gift of securities by or to the insider at price $ 0.00 per share. 26 Mar 2025 190,000 190,000 (0%) 0% 0 Common Stock
Michael I. Halstead President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2025 7,345 25,064 (0%) 0% - Common Stock
Michael I. Halstead President Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.24 per share. 06 Mar 2025 3,757 21,307 (0%) 0% 131.2 493,069 Common Stock
Michael I. Halstead President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2025 13,133 13,133 - - Restricted Stock Units
Michael I. Halstead President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2025 7,345 0 - - Restricted Stock Units
Michael I. Halstead President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2025 13,133 24,437 (0%) 0% - Common Stock
Michael I. Halstead President Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.19 per share. 06 Mar 2025 6,718 17,719 (0%) 0% 131.2 881,334 Common Stock
Sharon Mates Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2025 40,712 1,144,646 (1%) 0% - Common Stock
Sharon Mates Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2025 20,566 0 - - Restricted Stock Units
Sharon Mates Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2025 40,712 40,713 - - Restricted Stock Units
Sharon Mates Director, Chairman and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.24 per share. 06 Mar 2025 10,129 1,135,235 (1%) 0% 131.2 1,329,330 Common Stock
Sharon Mates Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2025 20,566 1,145,364 (1%) 0% - Common Stock
Sharon Mates Director, Chairman and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.19 per share. 06 Mar 2025 19,848 1,124,798 (1%) 0% 131.2 2,603,859 Common Stock
Mark Neumann EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2025 13,133 54,154 (0%) 0% - Common Stock
Mark Neumann EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2025 7,345 0 - - Restricted Stock Units
Mark Neumann EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2025 13,133 13,133 - - Restricted Stock Units
Mark Neumann EVP, Chief Commercial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.24 per share. 06 Mar 2025 3,116 52,811 (0%) 0% 131.2 408,944 Common Stock
Mark Neumann EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2025 7,345 55,927 (0%) 0% - Common Stock
Mark Neumann EVP, Chief Commercial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.19 per share. 06 Mar 2025 5,572 48,582 (0%) 0% 131.2 730,991 Common Stock
Suresh K. Durgam EVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2025 7,345 0 - - Restricted Stock Units
Suresh K. Durgam EVP, Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.19 per share. 06 Mar 2025 5,572 38,684 (0%) 0% 131.2 730,991 Common Stock
Suresh K. Durgam EVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2025 7,345 46,029 (0%) 0% - Common Stock
Suresh K. Durgam EVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2025 13,133 44,256 (0%) 0% - Common Stock
Suresh K. Durgam EVP, Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.24 per share. 06 Mar 2025 3,116 42,913 (0%) 0% 131.2 408,944 Common Stock
Suresh K. Durgam EVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2025 13,133 13,133 - - Restricted Stock Units
Michael I. Halstead President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2025 12,239 17,565 (0%) 0% - Common Stock
Michael I. Halstead President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2025 12,239 24,478 - - Restricted Stock Units
Michael I. Halstead President Payment of exercise price or tax liability using portion of securities received from the company at price $ 128.20 per share. 01 Mar 2025 6,261 11,304 (0%) 0% 128.2 802,660 Common Stock
Sharon Mates Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2025 34,969 69,940 - - Restricted Stock Units
Sharon Mates Director, Chairman and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 128.20 per share. 01 Mar 2025 16,978 1,103,934 (1%) 0% 128.2 2,176,580 Common Stock
Sharon Mates Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2025 34,969 1,120,912 (1%) 0% - Common Stock
Mark Neumann EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2025 8,742 44,730 (0%) 0% - Common Stock
Mark Neumann EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2025 8,742 17,485 - - Restricted Stock Units
Mark Neumann EVP, Chief Commercial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 128.20 per share. 01 Mar 2025 3,709 41,021 (0%) 0% 128.2 475,494 Common Stock
Suresh K. Durgam EVP, Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 128.20 per share. 01 Mar 2025 3,709 31,123 (0%) 0% 128.2 475,494 Common Stock
Suresh K. Durgam EVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2025 8,742 17,485 - - Restricted Stock Units
Suresh K. Durgam EVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2025 8,742 34,832 (0%) 0% - Common Stock
Joel S. Marcus Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.79 per share. 24 Feb 2025 7,009 48,238 (0%) 0% 63.8 447,104 Common Stock
Joel S. Marcus Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Feb 2025 7,009 0 - - Stock Option (right to buy)
Sanjeev Narula Executive Vice President & CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 22,727 22,727 - - Restricted Stock Units
Michael I. Halstead President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 11,017 11,017 (0%) 0% 0 Common Stock
Michael I. Halstead President Payment of exercise price or tax liability using portion of securities received from the company at price $ 127.00 per share. 31 Jan 2025 5,691 5,326 (0%) 0% 127 722,757 Common Stock
Michael I. Halstead President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 45,454 45,454 - - Restricted Stock Units
Sharon Mates Director, Chairman and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 121,212 121,212 - - Restricted Stock Units
Sharon Mates Director, Chairman and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 30,847 1,101,176 (1%) 0% 0 Common Stock
Sharon Mates Director, Chairman and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 127.00 per share. 31 Jan 2025 15,233 1,085,943 (1%) 0% 127 1,934,591 Common Stock
Mark Neumann EVP, Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 11,017 40,717 (0%) 0% 0 Common Stock
Mark Neumann EVP, Chief Commercial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 127.00 per share. 31 Jan 2025 4,729 35,988 (0%) 0% 127 600,583 Common Stock
Mark Neumann EVP, Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 22,727 22,727 - - Restricted Stock Units
Suresh K. Durgam EVP, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 11,017 30,820 (0%) 0% 0 Common Stock
Suresh K. Durgam EVP, Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 127.00 per share. 31 Jan 2025 4,730 26,090 (0%) 0% 127 600,710 Common Stock
Suresh K. Durgam EVP, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 24,621 24,621 - - Restricted Stock Units
Rory B. Riggs Director Grant, award, or other acquisition of securities at price $ 83.52 per share. 31 Dec 2024 215 131,512 (0%) 0% 83.5 17,957 Common Stock
Mates Sharon Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.73 per share. 04 Dec 2024 51,697 1,122,026 (1%) 0% 12.7 658,103 Common Stock
Sharon Mates Director, Chairman and CEO Sale of securities on an exchange or to another person at price $ 84.69 per share. 04 Dec 2024 1,534 1,070,329 (1%) 0% 84.7 129,914 Common Stock
Sharon Mates Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Dec 2024 51,000 51,697 - - Stock Option (right to buy)
Sharon Mates Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.73 per share. 04 Dec 2024 51,000 1,121,329 (1%) 0% 12.7 649,230 Common Stock
Mates Sharon Director, Chairman and CEO Sale of securities on an exchange or to another person at price $ 86.00 per share. 04 Dec 2024 23,333 1,070,329 (1%) 0% 86.0 2,006,750 Common Stock
Mates Sharon Director, Chairman and CEO Sale of securities on an exchange or to another person at price $ 85.62 per share. 04 Dec 2024 27,667 1,093,662 (1%) 0% 85.6 2,368,909 Common Stock
Mates Sharon Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Dec 2024 51,697 0 - - Stock Option (right to buy)
Sharon Mates Director, Chairman and CEO Sale of securities on an exchange or to another person at price $ 84.06 per share. 04 Dec 2024 50,163 1,071,863 (1%) 0% 84.1 4,216,928 Common Stock
Michael I. Halstead President Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.94 per share. 12 Nov 2024 22,869 22,869 (0%) 0% 23.9 547,484 Common Stock
Michael I. Halstead President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Nov 2024 22,869 0 - - Stock Option (right to buy)
Michael I. Halstead President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Nov 2024 18,714 0 - - Stock Option (right to buy)
Michael I. Halstead President Sale of securities on an exchange or to another person at price $ 88.92 per share. 12 Nov 2024 5,343 0 (0%) 0% 88.9 475,100 Common Stock
Michael I. Halstead President Sale of securities on an exchange or to another person at price $ 88.17 per share. 12 Nov 2024 13,371 5,343 (0%) 0% 88.2 1,178,921 Common Stock
Michael I. Halstead President Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.89 per share. 12 Nov 2024 18,714 18,714 (0%) 0% 36.9 690,359 Common Stock
Michael I. Halstead President Sale of securities on an exchange or to another person at price $ 90.89 per share. 12 Nov 2024 1,648 0 (0%) 0% 90.9 149,787 Common Stock
Michael I. Halstead President Sale of securities on an exchange or to another person at price $ 89.63 per share. 12 Nov 2024 6,116 1,648 (0%) 0% 89.6 548,177 Common Stock
Michael I. Halstead President Sale of securities on an exchange or to another person at price $ 88.72 per share. 12 Nov 2024 15,105 7,764 (0%) 0% 88.7 1,340,116 Common Stock
Rory B. Riggs Director Grant, award, or other acquisition of securities at price $ 73.17 per share. 30 Sep 2024 246 117,108 (0%) 0% 73.2 18,000 Common Stock
Sharon Mates Director, Chairman and CEO Sale of securities on an exchange or to another person at price $ 73.32 per share. 29 Aug 2024 6,193 1,070,329 (1%) 0% 73.3 454,091 Common Stock
Sharon Mates Director, Chairman and CEO Sale of securities on an exchange or to another person at price $ 72.73 per share. 29 Aug 2024 28,203 1,076,522 (1%) 0% 72.7 2,051,261 Common Stock
Sharon Mates Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.73 per share. 29 Aug 2024 34,396 1,104,725 (1%) 0% 12.7 437,861 Common Stock
Sharon Mates Director, Chairman and CEO Sale of securities on an exchange or to another person at price $ 73.25 per share. 29 Aug 2024 5,772 1,070,329 (1%) 0% 73.2 422,771 Common Stock
Sharon Mates Director, Chairman and CEO Sale of securities on an exchange or to another person at price $ 72.44 per share. 29 Aug 2024 29,832 1,076,101 (1%) 0% 72.4 2,161,114 Common Stock
Sharon Mates Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.73 per share. 29 Aug 2024 35,604 1,105,933 (1%) 0% 12.7 453,239 Common Stock
Sharon Mates Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Aug 2024 34,396 102,697 - - Stock Option (right to buy)
Sharon Mates Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Aug 2024 35,604 137,093 - - Stock Option (right to buy)
Sharon Mates Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Aug 2024 40,513 32,699 - - Stock Option (right to buy)
Sharon Mates Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Aug 2024 22,713 73,212 - - Stock Option (right to buy)
Sharon Mates Director, Chairman and CEO Sale of securities on an exchange or to another person at price $ 73.70 per share. 26 Aug 2024 240 1,070,329 (1%) 0% 73.7 17,688 Common Stock
Sharon Mates Director, Chairman and CEO Sale of securities on an exchange or to another person at price $ 72.74 per share. 26 Aug 2024 32,459 1,070,569 (1%) 0% 72.7 2,361,113 Common Stock
Sharon Mates Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.57 per share. 26 Aug 2024 32,699 1,103,028 (1%) 0% 17.6 574,521 Common Stock
Sharon Mates Director, Chairman and CEO Sale of securities on an exchange or to another person at price $ 73.93 per share. 26 Aug 2024 16,856 1,070,329 (1%) 0% 73.9 1,246,191 Common Stock
Sharon Mates Director, Chairman and CEO Sale of securities on an exchange or to another person at price $ 73.33 per share. 26 Aug 2024 23,657 1,087,185 (1%) 0% 73.3 1,734,865 Common Stock
Sharon Mates Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.57 per share. 26 Aug 2024 40,513 1,110,842 (1%) 0% 17.6 711,813 Common Stock
Sharon Mates Director, Chairman and CEO Sale of securities on an exchange or to another person at price $ 74.59 per share. 26 Aug 2024 22,713 1,070,329 (1%) 0% 74.6 1,694,229 Common Stock
Sharon Mates Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.57 per share. 26 Aug 2024 22,713 1,093,042 (1%) 0% 17.6 399,067 Common Stock
Sharon Mates Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Aug 2024 32,699 0 - - Stock Option (right to buy)
Sharon Mates Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.57 per share. 21 Aug 2024 53,013 1,123,342 (1%) 0% 17.6 931,438 Common Stock
Sharon Mates Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Aug 2024 28,680 95,925 - - Stock Option (right to buy)
Sharon Mates Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Aug 2024 39,380 124,605 - - Stock Option (right to buy)
Sharon Mates Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Aug 2024 53,013 163,985 - - Stock Option (right to buy)
Sharon Mates Director, Chairman and CEO Sale of securities on an exchange or to another person at price $ 74.46 per share. 21 Aug 2024 28,680 1,070,329 (1%) 0% 74.5 2,135,435 Common Stock
Sharon Mates Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.57 per share. 21 Aug 2024 28,680 1,099,009 (1%) 0% 17.6 503,908 Common Stock
Sharon Mates Director, Chairman and CEO Sale of securities on an exchange or to another person at price $ 75.47 per share. 21 Aug 2024 4,369 1,070,329 (1%) 0% 75.5 329,727 Common Stock
Sharon Mates Director, Chairman and CEO Sale of securities on an exchange or to another person at price $ 74.58 per share. 21 Aug 2024 35,011 1,074,698 (1%) 0% 74.6 2,611,075 Common Stock
Sharon Mates Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.57 per share. 21 Aug 2024 39,380 1,109,709 (1%) 0% 17.6 691,907 Common Stock
Sharon Mates Director, Chairman and CEO Sale of securities on an exchange or to another person at price $ 77.98 per share. 21 Aug 2024 1,900 1,070,329 (1%) 0% 78.0 148,163 Common Stock
Sharon Mates Director, Chairman and CEO Sale of securities on an exchange or to another person at price $ 77.21 per share. 21 Aug 2024 2,682 1,072,229 (1%) 0% 77.2 207,088 Common Stock
Sharon Mates Director, Chairman and CEO Sale of securities on an exchange or to another person at price $ 76.20 per share. 21 Aug 2024 4,297 1,074,911 (1%) 0% 76.2 327,432 Common Stock
Sharon Mates Director, Chairman and CEO Sale of securities on an exchange or to another person at price $ 75.40 per share. 21 Aug 2024 44,134 1,079,208 (1%) 0% 75.4 3,327,818 Common Stock
Mark Neumann EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.89 per share. 16 Aug 2024 18,714 48,414 (0%) 0% 36.9 690,359 Common Stock
Mark Neumann EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Aug 2024 18,714 0 - - Stock Option (right to buy)
Mark Neumann EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 75.08 per share. 16 Aug 2024 18,714 29,700 (0%) 0% 75.1 1,405,047 Common Stock
Sanjeev Narula Executive Vice President & CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 17,251 17,251 - - Stock Option (right to buy)
Sanjeev Narula Executive Vice President & CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 35,046 35,046 - - Restricted Stock Units
Robert L. Van Nostrand Director Grant, award, or other acquisition of securities at price $ 68.49 per share. 28 Jun 2024 83 11,340 (0%) 0% 68.5 5,685 Common Stock
Rory B. Riggs Director Grant, award, or other acquisition of securities at price $ 68.49 per share. 28 Jun 2024 262 116,862 (0%) 0% 68.5 17,944 Common Stock
Joel S. Marcus Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Jun 2024 1,567 41,229 (0%) 0% - Common Stock
Joel S. Marcus Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Jun 2024 1,567 0 - - Restricted Stock Units
Robert L. Van Nostrand Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Jun 2024 1,567 0 - - Restricted Stock Units
Robert L. Van Nostrand Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Jun 2024 1,567 11,257 (0%) 0% - Common Stock
Rory B. Riggs Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Jun 2024 20,000 0 - - Stock Option (right to buy)
Rory B. Riggs Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Jun 2024 1,567 0 - - Restricted Stock Units
Rory B. Riggs Director Sale of securities on an exchange or to another person at price $ 75.57 per share. 23 Jun 2024 4,462 116,600 (0%) 0% 75.6 337,193 Common Stock
Rory B. Riggs Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.86 per share. 23 Jun 2024 20,000 121,062 (0%) 0% 16.9 337,200 Common Stock
Rory B. Riggs Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Jun 2024 1,567 101,062 (0%) 0% - Common Stock
Eduardo Rene Salas Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Jun 2024 1,567 0 - - Restricted Stock Units
Eduardo Rene Salas Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Jun 2024 1,567 1,567 (0%) 0% - Common Stock
Robert L. Van Nostrand Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.86 per share. 18 Jun 2024 20,000 29,690 (0%) 0% 16.9 337,200 Common Stock
Robert L. Van Nostrand Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jun 2024 20,000 0 - - Stock Option (right to buy)
Robert L. Van Nostrand Director Sale of securities on an exchange or to another person at price $ 76.07 per share. 18 Jun 2024 11,109 9,690 (0%) 0% 76.1 845,062 Common Stock
Robert L. Van Nostrand Director Sale of securities on an exchange or to another person at price $ 75.71 per share. 18 Jun 2024 8,891 20,799 (0%) 0% 75.7 673,138 Common Stock
Joel S. Marcus Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 2,951 2,951 - - Restricted Stock Units
Joel S. Marcus Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 4,322 4,322 - - Stock Option (right to buy)
Robert L. Van Nostrand Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 4,322 4,322 - - Stock Option (right to buy)
Robert L. Van Nostrand Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 2,951 2,951 - - Restricted Stock Units
Rory B. Riggs Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 4,322 4,322 - - Stock Option (right to buy)
Rory B. Riggs Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 2,951 2,951 - - Restricted Stock Units
Eduardo Rene Salas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 2,951 2,951 - - Restricted Stock Units
Eduardo Rene Salas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 4,322 4,322 - - Stock Option (right to buy)
Sharon Mates Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2024 11,382 216,998 - - Stock Option (right to buy)
Sharon Mates Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.86 per share. 24 Apr 2024 8,638 1,058,947 (1%) 0% 16.9 145,637 Common Stock
Sharon Mates Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.57 per share. 24 Apr 2024 11,382 1,070,329 (1%) 0% 17.6 199,982 Common Stock
Sharon Mates Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2024 8,638 0 - - Stock Option (right to buy)
Robert L. Van Nostrand Director Grant, award, or other acquisition of securities at price $ 69.20 per share. 31 Mar 2024 79 9,690 (0%) 0% 69.2 5,467 Common Stock
Rory B. Riggs Director Grant, award, or other acquisition of securities at price $ 69.20 per share. 31 Mar 2024 260 99,495 (0%) 0% 69.2 17,992 Common Stock
Rory B. Riggs Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Mar 2024 20,000 0 - - Stock Option (right to buy)
Rory B. Riggs Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.56 per share. 20 Mar 2024 20,000 99,235 (0%) 0% 18.6 371,200 Common Stock
Michael I. Halstead EVP and General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Mar 2024 7,345 7,345 - - Restricted Stock Units
Michael I. Halstead EVP and General Counsel Sale of securities on an exchange or to another person at price $ 66.70 per share. 07 Mar 2024 1,238 0 (0%) 0% 66.7 82,575 Common Stock
Michael I. Halstead EVP and General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Mar 2024 7,345 7,345 (0%) 0% - Common Stock
Michael I. Halstead EVP and General Counsel Sale of securities on an exchange or to another person at price $ 66.14 per share. 07 Mar 2024 12,912 220 (0%) 0% 66.1 854,000 Common Stock
Michael I. Halstead EVP and General Counsel Sale of securities on an exchange or to another person at price $ 65.82 per share. 07 Mar 2024 6,107 1,238 (0%) 0% 65.8 401,963 Common Stock
Michael I. Halstead EVP and General Counsel Sale of securities on an exchange or to another person at price $ 66.81 per share. 07 Mar 2024 220 0 (0%) 0% 66.8 14,698 Common Stock
Sharon Mates Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 64.80 per share. 07 Mar 2024 14,541 1,056,333 (1%) 0% 64.8 942,257 Common Stock
Sharon Mates Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 66.93 per share. 07 Mar 2024 8,754 1,050,309 (1%) 0% 66.9 585,905 Common Stock
Sharon Mates Director, Chairman, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Mar 2024 20,565 1,070,874 (1%) 0% - Common Stock
Sharon Mates Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 66.38 per share. 07 Mar 2024 31,958 1,059,063 (1%) 0% 66.4 2,121,372 Common Stock
Sharon Mates Director, Chairman, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Mar 2024 20,565 20,566 - - Restricted Stock Units
Sharon Mates Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 67.33 per share. 07 Mar 2024 306 1,050,309 (1%) 0% 67.3 20,603 Common Stock
Sharon Mates Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 66.81 per share. 07 Mar 2024 1,590 1,050,615 (1%) 0% 66.8 106,228 Common Stock
Sharon Mates Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 65.90 per share. 07 Mar 2024 4,128 1,052,205 (1%) 0% 65.9 272,035 Common Stock
Lawrence J. Hineline SVP of Finance, CFO Sale of securities on an exchange or to another person at price $ 66.93 per share. 07 Mar 2024 6,618 0 (0%) 0% 66.9 442,943 Common Stock
Lawrence J. Hineline SVP of Finance, CFO Sale of securities on an exchange or to another person at price $ 66.26 per share. 07 Mar 2024 6,514 6,618 (0%) 0% 66.3 431,618 Common Stock
Lawrence J. Hineline SVP of Finance, CFO Sale of securities on an exchange or to another person at price $ 67.12 per share. 07 Mar 2024 64 0 (0%) 0% 67.1 4,296 Common Stock
Lawrence J. Hineline SVP of Finance, CFO Sale of securities on an exchange or to another person at price $ 66.47 per share. 07 Mar 2024 4,475 64 (0%) 0% 66.5 297,453 Common Stock
Lawrence J. Hineline SVP of Finance, CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.73 per share. 07 Mar 2024 4,539 4,539 (0%) 0% 56.7 257,497 Common Stock
Lawrence J. Hineline SVP of Finance, CFO Sale of securities on an exchange or to another person at price $ 67.31 per share. 07 Mar 2024 29 0 (0%) 0% 67.3 1,952 Common Stock
Lawrence J. Hineline SVP of Finance, CFO Sale of securities on an exchange or to another person at price $ 66.54 per share. 07 Mar 2024 1,100 29 (0%) 0% 66.5 73,194 Common Stock
Lawrence J. Hineline SVP of Finance, CFO Sale of securities on an exchange or to another person at price $ 65.28 per share. 07 Mar 2024 4,453 1,129 (0%) 0% 65.3 290,692 Common Stock
Lawrence J. Hineline SVP of Finance, CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Mar 2024 5,582 5,582 (0%) 0% - Common Stock
Lawrence J. Hineline SVP of Finance, CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Mar 2024 4,539 4,539 - - Stock Option (right to purchase)
Lawrence J. Hineline SVP of Finance, CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Mar 2024 5,582 5,582 - - Restricted Stock Units
Mark Neumann EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Mar 2024 7,345 7,345 - - Restricted Stock Units
Mark Neumann EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 66.86 per share. 07 Mar 2024 1,313 29,700 (0%) 0% 66.9 87,787 Common Stock
Mark Neumann EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 65.92 per share. 07 Mar 2024 1,729 31,013 (0%) 0% 65.9 113,976 Common Stock
Mark Neumann EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 65.11 per share. 07 Mar 2024 4,303 32,742 (0%) 0% 65.1 280,168 Common Stock
Mark Neumann EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Mar 2024 7,345 37,045 (0%) 0% - Common Stock
Mark Neumann EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 66.95 per share. 07 Mar 2024 4,496 29,700 (0%) 0% 66.9 301,007 Common Stock
Mark Neumann EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 66.37 per share. 07 Mar 2024 8,636 34,196 (0%) 0% 66.4 573,171 Common Stock
Suresh K. Durgam EVP, Chief Medical Officer Sale of securities on an exchange or to another person at price $ 66.96 per share. 07 Mar 2024 661 19,803 (0%) 0% 67.0 44,261 Common Stock
Suresh K. Durgam EVP, Chief Medical Officer Sale of securities on an exchange or to another person at price $ 65.06 per share. 07 Mar 2024 2,179 21,336 (0%) 0% 65.1 141,766 Common Stock
Suresh K. Durgam EVP, Chief Medical Officer Sale of securities on an exchange or to another person at price $ 66.34 per share. 07 Mar 2024 3,728 18,892 (0%) 0% 66.3 247,316 Common Stock
Suresh K. Durgam EVP, Chief Medical Officer Sale of securities on an exchange or to another person at price $ 66.86 per share. 07 Mar 2024 2,722 16,170 (0%) 0% 66.9 181,993 Common Stock
Suresh K. Durgam EVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Mar 2024 7,345 23,515 (0%) 0% - Common Stock
Suresh K. Durgam EVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Mar 2024 7,345 7,345 - - Restricted Stock Units
Suresh K. Durgam EVP, Chief Medical Officer Sale of securities on an exchange or to another person at price $ 65.89 per share. 07 Mar 2024 872 20,464 (0%) 0% 65.9 57,456 Common Stock
Michael I. Halstead EVP and General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2024 13,132 26,266 - - Restricted Stock Units
Michael I. Halstead EVP and General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2024 13,132 13,132 (0%) 0% - Common Stock
Sharon Mates Director, Chairman, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2024 40,712 81,425 - - Restricted Stock Units
Sharon Mates Director, Chairman, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2024 40,712 1,091,021 (1%) 0% - Common Stock
Lawrence J. Hineline SVP of Finance, CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2024 13,132 26,266 - - Restricted Stock Units
Lawrence J. Hineline SVP of Finance, CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2024 13,132 13,132 (0%) 0% - Common Stock
Mark Neumann EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2024 13,132 26,266 - - Restricted Stock Units
Mark Neumann EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2024 13,132 42,832 (0%) 0% - Common Stock
Suresh K. Durgam EVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2024 13,132 26,266 - - Restricted Stock Units
Suresh K. Durgam EVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2024 13,132 22,620 (0%) 0% - Common Stock
Michael I. Halstead EVP and General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 36,717 36,717 - - Restricted Stock Units
Sharon Mates Director, Chairman, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 104,909 104,909 - - Restricted Stock Units
Lawrence J. Hineline SVP of Finance, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 26,227 26,227 - - Restricted Stock Units
Mark Neumann EVP, Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 26,227 26,227 - - Restricted Stock Units
Suresh K. Durgam EVP, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 26,227 26,227 - - Restricted Stock Units
Van Nostrand L. Robert Director Sale of securities on an exchange or to another person at price $ 73.14 per share. 27 Feb 2024 10,349 9,611 (0%) 0% 73.1 756,926 Common Stock
L. Robert Van Nostrand Director Sale of securities on an exchange or to another person at price $ 72.71 per share. 27 Feb 2024 9,651 19,960 (0%) 0% 72.7 701,724 Common Stock
L. Robert Van Nostrand Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.56 per share. 27 Feb 2024 20,000 29,611 (0%) 0% 18.6 371,200 Common Stock
Robert L. Van Nostrand Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Feb 2024 20,000 0 - - Stock Option (right to buy)
S. Joel Marcus Director Sale of securities on an exchange or to another person at price $ 67.83 per share. 26 Feb 2024 8,371 57,619 (0%) 0% 67.8 567,805 Common Stock
Joel Marcus S. Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.45 per share. 26 Feb 2024 20,000 49,233 (0%) 0% 43.5 869,000 Common Stock
Marcus Joel S. Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Feb 2024 20,000 0 - - Stock Option (right to buy)
Joel S. Marcus Director Sale of securities on an exchange or to another person at price $ 69.60 per share. 26 Feb 2024 299 39,662 (0%) 0% 69.6 20,810 Common Stock
S. Joel Marcus Director Sale of securities on an exchange or to another person at price $ 69.07 per share. 26 Feb 2024 17,658 39,961 (0%) 0% 69.1 1,219,638 Common Stock
S. Marcus Joel Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 55.48 per share. 26 Feb 2024 16,757 65,990 (0%) 0% 55.5 929,678 Common Stock
Marcus S. Joel Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Feb 2024 16,757 0 - - Stock Option (right to buy)
Mates Sharon Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 69.45 per share. 23 Feb 2024 9,528 1,062,771 (1%) 0% 69.5 661,720 Common Stock
Sharon Mates Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 70.11 per share. 23 Feb 2024 12,462 1,050,309 (1%) 0% 70.1 873,711 Common Stock
Mark Neumann EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 71.18 per share. 23 Feb 2024 1,307 29,700 (0%) 0% 71.2 93,032 Common Stock
Mark Neumann EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Feb 2024 7,907 0 - - Restricted Stock Units
J. Lawrence Hineline SVP of Finance, CFO Sale of securities on an exchange or to another person at price $ 69.47 per share. 23 Feb 2024 5,282 600 (0%) 0% 69.5 366,941 Common Stock
Suresh K. Durgam EVP, Chief Medical Officer Sale of securities on an exchange or to another person at price $ 70.16 per share. 23 Feb 2024 1,400 10,800 (0%) 0% 70.2 98,224 Common Stock
Michael Halstead I. EVP and General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Feb 2024 7,907 7,907 (0%) 0% - Common Stock
K. Durgam Suresh EVP, Chief Medical Officer Sale of securities on an exchange or to another person at price $ 71.02 per share. 23 Feb 2024 1,312 9,488 (0%) 0% 71.0 93,178 Common Stock
Neumann Mark EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 70.70 per share. 23 Feb 2024 2,341 31,007 (0%) 0% 70.7 165,509 Common Stock
Lawrence J. Hineline SVP of Finance, CFO Sale of securities on an exchange or to another person at price $ 68.33 per share. 23 Feb 2024 300 7,155 (0%) 0% 68.3 20,499 Common Stock
J. Lawrence Hineline SVP of Finance, CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Feb 2024 7,455 0 - - Restricted Stock Units
Lawrence J. Hineline SVP of Finance, CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Feb 2024 5,882 0 - - Stock Option (right to buy)
Michael I. Halstead EVP and General Counsel Sale of securities on an exchange or to another person at price $ 68.54 per share. 23 Feb 2024 300 7,607 (0%) 0% 68.5 20,562 Common Stock
Michael I. Halstead EVP and General Counsel Sale of securities on an exchange or to another person at price $ 70.13 per share. 23 Feb 2024 392 0 (0%) 0% 70.1 27,491 Common Stock
Hineline J. Lawrence SVP of Finance, CFO Sale of securities on an exchange or to another person at price $ 69.81 per share. 23 Feb 2024 600 0 (0%) 0% 69.8 41,886 Common Stock
Michael Halstead I. EVP and General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Feb 2024 7,907 0 - - Restricted Stock Units
I. Halstead Michael EVP and General Counsel Sale of securities on an exchange or to another person at price $ 69.54 per share. 23 Feb 2024 7,215 392 (0%) 0% 69.5 501,731 Common Stock
Mates Sharon Director, Chairman, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Feb 2024 22,590 1,072,899 (1%) 0% - Common Stock
Neumann Mark EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 69.56 per share. 23 Feb 2024 4,059 33,348 (0%) 0% 69.6 282,344 Common Stock
Mates Sharon Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 68.39 per share. 23 Feb 2024 600 1,072,299 (1%) 0% 68.4 41,034 Common Stock
Mates Sharon Director, Chairman, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Feb 2024 22,590 0 - - Restricted Stock Units
K. Durgam Suresh EVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Feb 2024 7,907 13,600 (0%) 0% - Common Stock
Neumann Mark EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Feb 2024 7,907 37,607 (0%) 0% - Common Stock
Mark Neumann EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 68.03 per share. 23 Feb 2024 200 37,407 (0%) 0% 68.0 13,606 Common Stock
Durgam K. Suresh EVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Feb 2024 7,907 0 - - Restricted Stock Units
J. Hineline Lawrence SVP of Finance, CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.89 per share. 23 Feb 2024 5,882 5,882 (0%) 0% 36.9 216,987 Common Stock
K. Suresh Durgam EVP, Chief Medical Officer Sale of securities on an exchange or to another person at price $ 69.38 per share. 23 Feb 2024 1,400 12,200 (0%) 0% 69.4 97,132 Common Stock
Hineline J. Lawrence SVP of Finance, CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Feb 2024 7,455 7,455 (0%) 0% - Common Stock
Lawrence Hineline J. SVP of Finance, CFO Sale of securities on an exchange or to another person at price $ 69.38 per share. 23 Feb 2024 6,867 288 (0%) 0% 69.4 476,432 Common Stock
J. Lawrence Hineline SVP of Finance, CFO Sale of securities on an exchange or to another person at price $ 70.15 per share. 23 Feb 2024 288 0 (0%) 0% 70.1 20,203 Common Stock
Neumann Mark EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 67.49 per share. 01 Feb 2024 6,904 29,700 (0%) 0% 67.5 465,951 Common Stock
Suresh Durgam K. EVP, Chief Medical Officer Sale of securities on an exchange or to another person at price $ 66.69 per share. 01 Feb 2024 2,320 9,540 (0%) 0% 66.7 154,721 Common Stock
Suresh Durgam K. EVP, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 11,860 11,860 (0%) 0% 0 Common Stock
I. Halstead Michael EVP and General Counsel Sale of securities on an exchange or to another person at price $ 66.37 per share. 01 Feb 2024 11,146 714 (0%) 0% 66.4 739,760 Common Stock
Lawrence J. Hineline SVP of Finance, CFO Sale of securities on an exchange or to another person at price $ 66.61 per share. 01 Feb 2024 10,998 185 (0%) 0% 66.6 732,577 Common Stock
Sharon Mates Director, Chairman, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 33,885 1,084,194 (1%) 0% 0 Common Stock
Suresh K. Durgam EVP, Chief Medical Officer Sale of securities on an exchange or to another person at price $ 67.49 per share. 01 Feb 2024 3,847 5,693 (0%) 0% 67.5 259,634 Common Stock
J. Hineline Lawrence SVP of Finance, CFO Sale of securities on an exchange or to another person at price $ 67.35 per share. 01 Feb 2024 185 0 (0%) 0% 67.4 12,460 Common Stock
Michael I. Halstead EVP and General Counsel Sale of securities on an exchange or to another person at price $ 67.17 per share. 01 Feb 2024 714 0 (0%) 0% 67.2 47,959 Common Stock
I. Michael Halstead EVP and General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 11,860 11,860 (0%) 0% 0 Common Stock
Lawrence Hineline J. SVP of Finance, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 11,183 11,183 (0%) 0% 0 Common Stock
Neumann Mark EVP, Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 11,860 41,560 (0%) 0% 0 Common Stock
Mates Sharon Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 67.42 per share. 01 Feb 2024 17,450 1,050,309 (1%) 0% 67.4 1,176,479 Common Stock
Mark Neumann EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 66.67 per share. 01 Feb 2024 4,956 36,604 (0%) 0% 66.7 330,417 Common Stock
Mates Sharon Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 66.70 per share. 01 Feb 2024 16,435 1,067,759 (1%) 0% 66.7 1,096,215 Common Stock
Mates Sharon Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 65.19 per share. 16 Jan 2024 67,597 1,050,629 (1%) 0% 65.2 4,406,648 Common Stock
Mates Sharon Director, Chairman, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.86 per share. 16 Jan 2024 48,084 1,098,393 (1%) 0% 16.9 810,696 Common Stock
Mates Sharon Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 66.66 per share. 16 Jan 2024 17,451 1,050,309 (1%) 0% 66.7 1,163,284 Common Stock
Sharon Mates Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 67.76 per share. 16 Jan 2024 5,882 1,050,309 (1%) 0% 67.8 398,564 Common Stock
Sharon Mates Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 66.00 per share. 16 Jan 2024 30,633 1,067,760 (1%) 0% 66 2,021,778 Common Stock
Mates Sharon Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 66.38 per share. 16 Jan 2024 3,500 1,122,170 (1%) 0% 66.4 232,330 Common Stock
Mates Sharon Director, Chairman, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Jan 2024 48,084 76,555 - - Stock Option (right to buy)
Mates Sharon Director, Chairman, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Jan 2024 67,917 8,638 - - Stock Option (right to buy)
Sharon Mates Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 66.25 per share. 16 Jan 2024 320 1,050,309 (1%) 0% 66.3 21,200 Common Stock
Sharon Mates Director, Chairman, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Jan 2024 75,361 124,639 - - Stock Option (right to buy)
Sharon Mates Director, Chairman, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.86 per share. 16 Jan 2024 67,917 1,118,226 (1%) 0% 16.9 1,145,081 Common Stock
Sharon Mates Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 67.25 per share. 16 Jan 2024 65,979 1,056,191 (1%) 0% 67.3 4,437,088 Common Stock
Mates Sharon Director, Chairman, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.86 per share. 16 Jan 2024 75,361 1,125,670 (1%) 0% 16.9 1,270,586 Common Stock
Michael I. Halstead EVP and General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.73 per share. 11 Jan 2024 46,115 46,115 (0%) 0% 12.7 587,044 Common Stock
Michael I. Halstead EVP and General Counsel Sale of securities on an exchange or to another person at price $ 67.80 per share. 11 Jan 2024 1,486 0 (0%) 0% 67.8 100,751 Common Stock
Michael Halstead I. EVP and General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Jan 2024 46,115 0 - - Stock Option (right to buy)
Michael Halstead I. EVP and General Counsel Sale of securities on an exchange or to another person at price $ 66.31 per share. 11 Jan 2024 18,154 31,846 (0%) 0% 66.3 1,203,792 Common Stock
Michael Halstead I. EVP and General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Jan 2024 3,885 22,869 - - Stock Option (right to buy)
I. Halstead Michael EVP and General Counsel Sale of securities on an exchange or to another person at price $ 67.10 per share. 11 Jan 2024 30,360 1,486 (0%) 0% 67.1 2,037,156 Common Stock
Halstead I. Michael EVP and General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.94 per share. 11 Jan 2024 3,885 50,000 (0%) 0% 23.9 93,007 Common Stock
Suresh K. Durgam EVP, Chief Medical Officer Sale of securities on an exchange or to another person at price $ 70.80 per share. 02 Jan 2024 22,645 2,210 (0%) 0% 70.8 1,603,266 Common Stock
Durgam Suresh K. EVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jan 2024 62,282 0 - - Stock Option (right to buy)
Durgam Suresh K. EVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.87 per share. 02 Jan 2024 62,282 62,282 (0%) 0% 19.9 1,237,543 Common Stock
K. Durgam Suresh EVP, Chief Medical Officer Sale of securities on an exchange or to another person at price $ 71.77 per share. 02 Jan 2024 2,210 0 (0%) 0% 71.8 158,612 Common Stock
K. Suresh Durgam EVP, Chief Medical Officer Sale of securities on an exchange or to another person at price $ 70.41 per share. 02 Jan 2024 37,427 24,855 (0%) 0% 70.4 2,635,235 Common Stock
Van Nostrand L. Robert Director Grant, award, or other acquisition of securities at price $ 71.62 per share. 31 Dec 2023 76 9,611 (0%) 0% 71.6 5,443 Common Stock
B. Riggs Rory Director Grant, award, or other acquisition of securities at price $ 71.62 per share. 31 Dec 2023 251 79,235 (0%) 0% 71.6 17,977 Common Stock
Durgam Suresh K. EVP, Chief Medical Officer Sale of securities on an exchange or to another person at price $ 65.00 per share. 13 Dec 2023 21,262 0 (0%) 0% 65 1,382,030 Common Stock
Mark Neumann EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Aug 2023 55,300 0 - - Stock Option (right to buy)
Mark Neumann EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 58.79 per share. 07 Aug 2023 55,300 45,339 (0%) 0% 58.8 3,251,087 Common Stock
Mark Neumann EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.59 per share. 07 Aug 2023 55,300 100,639 (0%) 0% 18.6 1,028,027 Common Stock
Suresh K. Durgam EVP, Chief Medical Officer Sale of securities on an exchange or to another person at price $ 65.00 per share. 17 Jul 2023 1,842 21,262 (0%) 0% 65 119,730 Common Stock
Robert L. Van Nostrand Director Grant, award, or other acquisition of securities at price $ 63.32 per share. 30 Jun 2023 85 9,430 (0%) 0% 63.3 5,382 Common Stock
Rory B. Riggs Director Grant, award, or other acquisition of securities at price $ 63.32 per share. 30 Jun 2023 279 78,639 (0%) 0% 63.3 17,666 Common Stock
Joel S. Marcus Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2023 7,009 7,009 - - Stock Option (right to buy)
Joel S. Marcus Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2023 1,567 1,567 - - Restricted Stock Units
Robert L. Van Nostrand Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2023 1,567 1,567 - - Restricted Stock Units
Robert L. Van Nostrand Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2023 7,009 7,009 - - Stock Option (right to buy)
Rory B. Riggs Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2023 7,009 7,009 - - Stock Option (right to buy)
Rory B. Riggs Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2023 1,567 1,567 - - Restricted Stock Units
Eduardo Rene Salas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2023 1,567 1,567 - - Restricted Stock Units
Eduardo Rene Salas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2023 7,009 7,009 - - Stock Option (right to buy)
Lawrence J. Hineline SVP of Finance CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Jun 2023 11,762 5,882 - - Stock Option (right to purchase)
Lawrence J. Hineline SVP of Finance CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Jun 2023 4,538 9,078 - - Stock Option (right to purchase)
Lawrence J. Hineline SVP of Finance CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Jun 2023 25,082 0 - - Stock Option (right to purchase)
Lawrence J. Hineline SVP of Finance CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Jun 2023 40,472 0 - - Stock Option (right to purchase)
Lawrence J. Hineline SVP of Finance CFO Sale of securities on an exchange or to another person at price $ 65.01 per share. 14 Jun 2023 3,592 0 (0%) 0% 65.0 233,516 Common Stock
Lawrence J. Hineline SVP of Finance CFO Sale of securities on an exchange or to another person at price $ 64.37 per share. 14 Jun 2023 44,035 3,592 (0%) 0% 64.4 2,834,533 Common Stock
Lawrence J. Hineline SVP of Finance CFO Sale of securities on an exchange or to another person at price $ 63.35 per share. 14 Jun 2023 34,227 47,627 (0%) 0% 63.3 2,168,280 Common Stock
Lawrence J. Hineline SVP of Finance CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.73 per share. 14 Jun 2023 4,538 81,854 (0%) 0% 56.7 257,441 Common Stock
Lawrence J. Hineline SVP of Finance CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.89 per share. 14 Jun 2023 11,762 77,316 (0%) 0% 36.9 433,900 Common Stock
Lawrence J. Hineline SVP of Finance CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.94 per share. 14 Jun 2023 25,082 65,554 (0%) 0% 23.9 600,463 Common Stock
Lawrence J. Hineline SVP of Finance CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.63 per share. 14 Jun 2023 40,472 40,472 (0%) 0% 53.6 2,170,513 Common Stock
Robert L. Van Nostrand Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.05 per share. 17 Apr 2023 10,000 19,345 (0%) 0% 13.1 130,500 Common Stock
Robert L. Van Nostrand Director Sale of securities on an exchange or to another person at price $ 63.00 per share. 17 Apr 2023 10,000 9,345 (0%) 0% 63 630,000 Common Stock
Robert L. Van Nostrand Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Apr 2023 10,000 0 - - Stock Option (right to buy)
Robert L. Van Nostrand Director Grant, award, or other acquisition of securities at price $ 54.15 per share. 31 Mar 2023 95 9,345 (0%) 0% 54.1 5,144 Common Stock
Rory B. Riggs Director Grant, award, or other acquisition of securities at price $ 54.15 per share. 31 Mar 2023 313 78,360 (0%) 0% 54.2 16,949 Common Stock
Mark Neumann EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 54.86 per share. 28 Mar 2023 5,421 55,522 (0%) 0% 54.9 297,396 Common Stock
Mark Neumann EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 54.01 per share. 28 Mar 2023 10,183 45,339 (0%) 0% 54.0 549,984 Common Stock
Suresh K. Durgam EVP, Chief Medical Officer Sale of securities on an exchange or to another person at price $ 44.29 per share. 10 Mar 2023 346 23,104 (0%) 0% 44.3 15,324 Common Stock
Suresh K. Durgam EVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Mar 2023 7,344 30,448 (0%) 0% - Common Stock
Suresh K. Durgam EVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Mar 2023 7,344 14,690 - - Restricted Stock Units
Suresh K. Durgam EVP, Chief Medical Officer Sale of securities on an exchange or to another person at price $ 45.08 per share. 10 Mar 2023 6,998 23,450 (0%) 0% 45.1 315,470 Common Stock
Michael I. Halstead EVP and General Counsel Sale of securities on an exchange or to another person at price $ 42.52 per share. 09 Mar 2023 2,500 0 (0%) 0% 42.5 106,300 Common Stock
Michael I. Halstead EVP and General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2023 16,708 16,708 (0%) 0% 0 Common Stock
Michael I. Halstead EVP and General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Mar 2023 7,344 14,690 - - Restricted Stock Units
Michael I. Halstead EVP and General Counsel Sale of securities on an exchange or to another person at price $ 44.15 per share. 09 Mar 2023 476 0 (0%) 0% 44.1 21,015 Common Stock
Michael I. Halstead EVP and General Counsel Sale of securities on an exchange or to another person at price $ 44.99 per share. 09 Mar 2023 6,868 476 (0%) 0% 45.0 308,991 Common Stock
Michael I. Halstead EVP and General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Mar 2023 7,344 7,344 (0%) 0% - Common Stock
Michael I. Halstead EVP and General Counsel Sale of securities on an exchange or to another person at price $ 43.20 per share. 09 Mar 2023 14,208 2,500 (0%) 0% 43.2 613,786 Common Stock
Sharon Mates Director, Chairman, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.26 per share. 09 Mar 2023 20,000 1,150,309 (1%) 0% 3.3 65,200 Common Stock
Sharon Mates Director, Chairman, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2023 41,770 1,172,079 (1%) 0% 0 Common Stock
Sharon Mates Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 43.28 per share. 09 Mar 2023 34,965 1,137,114 (1%) 0% 43.3 1,513,285 Common Stock
Sharon Mates Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 42.51 per share. 09 Mar 2023 6,805 1,130,309 (1%) 0% 42.5 289,281 Common Stock
Sharon Mates Director, Chairman, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Mar 2023 20,565 1,150,874 (1%) 0% - Common Stock
Sharon Mates Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 45.06 per share. 09 Mar 2023 19,153 1,131,721 (1%) 0% 45.1 863,034 Common Stock
Sharon Mates Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 44.08 per share. 09 Mar 2023 1,412 1,130,309 (1%) 0% 44.1 62,241 Common Stock
Sharon Mates Director, Chairman, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Mar 2023 20,565 41,131 - - Restricted Stock Units
Sharon Mates Director, Chairman, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Mar 2023 20,000 0 - - Stock Option (right to buy)
Lawrence J. Hineline SVP of Finance CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Mar 2023 5,582 11,164 - - Restricted Stock Units
Lawrence J. Hineline SVP of Finance CFO Sale of securities on an exchange or to another person at price $ 44.14 per share. 09 Mar 2023 258 0 (0%) 0% 44.1 11,388 Common Stock
Lawrence J. Hineline SVP of Finance CFO Sale of securities on an exchange or to another person at price $ 44.97 per share. 09 Mar 2023 5,324 258 (0%) 0% 45.0 239,420 Common Stock
Lawrence J. Hineline SVP of Finance CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Mar 2023 5,582 5,582 (0%) 0% - Common Stock
Lawrence J. Hineline SVP of Finance CFO Sale of securities on an exchange or to another person at price $ 42.52 per share. 09 Mar 2023 2,700 0 (0%) 0% 42.5 114,804 Common Stock
Lawrence J. Hineline SVP of Finance CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2023 15,663 15,663 (0%) 0% 0 Common Stock
Lawrence J. Hineline SVP of Finance CFO Sale of securities on an exchange or to another person at price $ 43.17 per share. 09 Mar 2023 12,963 2,700 (0%) 0% 43.2 559,613 Common Stock
Mark Neumann EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 43.50 per share. 09 Mar 2023 6,750 59,157 (0%) 0% 43.5 293,625 Common Stock
Mark Neumann EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Mar 2023 7,344 14,690 - - Restricted Stock Units
Mark Neumann EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 44.05 per share. 09 Mar 2023 423 60,943 (0%) 0% 44.0 18,633 Common Stock
Mark Neumann EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 45.10 per share. 09 Mar 2023 3,335 61,366 (0%) 0% 45.1 150,409 Common Stock
Mark Neumann EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Mar 2023 7,344 64,701 (0%) 0% - Common Stock
Mark Neumann EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 42.74 per share. 09 Mar 2023 1,800 57,357 (0%) 0% 42.7 76,932 Common Stock
Mark Neumann EVP, Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2023 16,708 65,907 (0%) 0% 0 Common Stock
Michael I. Halstead EVP and General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2023 39,398 39,398 - - Restricted Stock Units
Sharon Mates Director, Chairman, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2023 122,137 122,137 - - Restricted Stock Units
Lawrence J. Hineline SVP of Finance CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2023 39,398 39,398 - - Restricted Stock Units
Mark Neumann EVP, Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2023 39,398 39,398 - - Restricted Stock Units
Suresh K. Durgam EVP, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2023 39,398 39,398 - - Restricted Stock Units
Mark Neumann EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 50.01 per share. 01 Mar 2023 7,241 49,199 (0%) 0% 50.0 362,122 Common Stock
Michael I. Halstead EVP and General Counsel Sale of securities on an exchange or to another person at price $ 47.03 per share. 23 Feb 2023 7,906 0 (0%) 0% 47.0 371,819 Common Stock
Michael I. Halstead EVP and General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Feb 2023 7,906 7,907 - - Restricted Stock Units
Michael I. Halstead EVP and General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Feb 2023 7,906 7,906 (0%) 0% - Common Stock
Sharon Mates Director, Chairman, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Feb 2023 22,590 1,122,899 (1%) 0% - Common Stock
Sharon Mates Director, Chairman, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.26 per share. 23 Feb 2023 30,000 1,130,309 (1%) 0% 3.3 97,800 Common Stock
Sharon Mates Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 47.03 per share. 23 Feb 2023 22,590 1,100,309 (1%) 0% 47.0 1,062,408 Common Stock
Sharon Mates Director, Chairman, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Feb 2023 30,000 20,000 - - Stock Option (right to buy)
Sharon Mates Director, Chairman, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Feb 2023 22,590 22,590 - - Restricted Stock Units
Lawrence J. Hineline SVP of Finance CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Feb 2023 7,455 7,455 (0%) 0% - Common Stock
Lawrence J. Hineline SVP of Finance CFO Sale of securities on an exchange or to another person at price $ 47.03 per share. 23 Feb 2023 7,455 0 (0%) 0% 47.0 350,609 Common Stock
Lawrence J. Hineline SVP of Finance CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Feb 2023 7,455 7,455 - - Restricted Stock Units
Mark Neumann EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Feb 2023 7,906 60,486 (0%) 0% - Common Stock
Mark Neumann EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Feb 2023 7,906 7,907 - - Restricted Stock Units
Mark Neumann EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 47.12 per share. 23 Feb 2023 4,046 56,440 (0%) 0% 47.1 190,648 Common Stock
Suresh K. Durgam SVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Feb 2023 7,906 7,907 - - Restricted Stock Units
Suresh K. Durgam SVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Feb 2023 7,906 31,010 (0%) 0% - Common Stock
Suresh K. Durgam SVP, Chief Medical Officer Sale of securities on an exchange or to another person at price $ 47.14 per share. 23 Feb 2023 7,906 23,104 (0%) 0% 47.1 372,689 Common Stock
Michael I. Halstead EVP and General Counsel Sale of securities on an exchange or to another person at price $ 49.60 per share. 18 Feb 2023 100 0 (0%) 0% 49.6 4,960 Common Stock
Michael I. Halstead EVP and General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2023 11,139 11,139 (0%) 0% - Common Stock
Michael I. Halstead EVP and General Counsel Sale of securities on an exchange or to another person at price $ 46.56 per share. 18 Feb 2023 9,296 1,843 (0%) 0% 46.6 432,822 Common Stock
Michael I. Halstead EVP and General Counsel Sale of securities on an exchange or to another person at price $ 47.23 per share. 18 Feb 2023 643 1,200 (0%) 0% 47.2 30,369 Common Stock
Michael I. Halstead EVP and General Counsel Sale of securities on an exchange or to another person at price $ 48.68 per share. 18 Feb 2023 1,100 100 (0%) 0% 48.7 53,548 Common Stock
Michael I. Halstead EVP and General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2023 11,139 0 - - Restricted Stock Units
Sharon Mates Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 47.35 per share. 18 Feb 2023 2,200 1,103,062 (1%) 0% 47.4 104,170 Common Stock
Sharon Mates Director, Chairman, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2023 27,848 0 - - Restricted Stock Units
Sharon Mates Director, Chairman, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2023 27,848 1,128,157 (1%) 0% - Common Stock
Sharon Mates Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 48.70 per share. 18 Feb 2023 2,502 1,100,560 (1%) 0% 48.7 121,847 Common Stock
Sharon Mates Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 49.60 per share. 18 Feb 2023 251 1,100,309 (1%) 0% 49.6 12,450 Common Stock
Sharon Mates Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 46.54 per share. 18 Feb 2023 22,895 1,105,262 (1%) 0% 46.5 1,065,533 Common Stock
Lawrence J. Hineline SVP of Finance CFO Sale of securities on an exchange or to another person at price $ 50.59 per share. 18 Feb 2023 1,689 0 (0%) 0% 50.6 85,447 Common Stock
Lawrence J. Hineline SVP of Finance CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2023 10,443 0 - - Restricted Stock Units
Lawrence J. Hineline SVP of Finance CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.73 per share. 18 Feb 2023 53,968 53,968 (0%) 0% 12.7 687,013 Common Stock
Lawrence J. Hineline SVP of Finance CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2023 53,968 0 - - Stock Option (right to buy)
Lawrence J. Hineline SVP of Finance CFO Sale of securities on an exchange or to another person at price $ 49.60 per share. 18 Feb 2023 94 0 (0%) 0% 49.6 4,662 Common Stock
Lawrence J. Hineline SVP of Finance CFO Sale of securities on an exchange or to another person at price $ 48.72 per share. 18 Feb 2023 900 94 (0%) 0% 48.7 43,848 Common Stock
Lawrence J. Hineline SVP of Finance CFO Sale of securities on an exchange or to another person at price $ 47.32 per share. 18 Feb 2023 800 994 (0%) 0% 47.3 37,856 Common Stock
Lawrence J. Hineline SVP of Finance CFO Sale of securities on an exchange or to another person at price $ 46.54 per share. 18 Feb 2023 8,649 1,794 (0%) 0% 46.5 402,524 Common Stock
Lawrence J. Hineline SVP of Finance CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2023 10,443 10,443 (0%) 0% - Common Stock
Lawrence J. Hineline SVP of Finance CFO Sale of securities on an exchange or to another person at price $ 49.81 per share. 18 Feb 2023 52,279 1,689 (0%) 0% 49.8 2,604,017 Common Stock
Mark Neumann EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 46.61 per share. 18 Feb 2023 3,140 53,338 (0%) 0% 46.6 146,355 Common Stock
Mark Neumann EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 47.32 per share. 18 Feb 2023 123 53,215 (0%) 0% 47.3 5,820 Common Stock
Mark Neumann EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 48.93 per share. 18 Feb 2023 635 52,580 (0%) 0% 48.9 31,071 Common Stock
Mark Neumann EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2023 11,139 0 - - Restricted Stock Units
Mark Neumann EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2023 11,139 56,478 (0%) 0% - Common Stock
Suresh K. Durgam SVP, Chief Medical Officer Sale of securities on an exchange or to another person at price $ 48.63 per share. 18 Feb 2023 806 23,179 (0%) 0% 48.6 39,196 Common Stock
Suresh K. Durgam SVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2023 8,354 0 - - Restricted Stock Units
Suresh K. Durgam SVP, Chief Medical Officer Sale of securities on an exchange or to another person at price $ 49.60 per share. 18 Feb 2023 75 23,104 (0%) 0% 49.6 3,720 Common Stock
Suresh K. Durgam SVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2023 8,354 31,458 (0%) 0% - Common Stock
Suresh K. Durgam SVP, Chief Medical Officer Sale of securities on an exchange or to another person at price $ 46.55 per share. 18 Feb 2023 6,673 24,785 (0%) 0% 46.5 310,628 Common Stock
Suresh K. Durgam SVP, Chief Medical Officer Sale of securities on an exchange or to another person at price $ 47.20 per share. 18 Feb 2023 800 23,985 (0%) 0% 47.2 37,760 Common Stock
Robert L. Van Nostrand Director Grant, award, or other acquisition of securities at price $ 52.92 per share. 30 Dec 2022 97 9,250 (0%) 0% 52.9 5,133 Common Stock
Rory B. Riggs Director Grant, award, or other acquisition of securities at price $ 52.92 per share. 30 Dec 2022 321 78,047 (0%) 0% 52.9 16,987 Common Stock
Joel S. Marcus Director Sale of securities on an exchange or to another person at price $ 50.82 per share. 19 Dec 2022 5,000 29,233 (0%) 0% 50.8 254,100 Common Stock
Sharon Mates Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 55.00 per share. 13 Dec 2022 33,083 1,100,309 (1%) 0% 55 1,819,565 Common Stock
Michael I. Halstead EVP and General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Dec 2022 50,000 15,164 - - Stock Option (right to buy)
Michael I. Halstead EVP and General Counsel Sale of securities on an exchange or to another person at price $ 53.94 per share. 01 Dec 2022 27,204 22,796 (0%) 0% 53.9 1,467,384 Common Stock
Michael I. Halstead EVP and General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.47 per share. 01 Dec 2022 50,000 50,000 (0%) 0% 15.5 773,500 Common Stock
Michael I. Halstead EVP and General Counsel Sale of securities on an exchange or to another person at price $ 53.48 per share. 01 Dec 2022 22,796 0 (0%) 0% 53.5 1,219,130 Common Stock
Joel S. Marcus Director Sale of securities on an exchange or to another person at price $ 52.11 per share. 07 Nov 2022 5,000 34,233 (0%) 0% 52.1 260,559 Common Stock
Joel S. Marcus Director Sale of securities on an exchange or to another person at price $ 52.49 per share. 07 Nov 2022 5,000 39,233 (0%) 0% 52.5 262,465 Common Stock
Robert L. Van Nostrand Director Grant, award, or other acquisition of securities at price $ 46.53 per share. 30 Sep 2022 110 9,153 (0%) 0% 46.5 5,118 Common Stock
Rory B. Riggs Director Grant, award, or other acquisition of securities at price $ 46.53 per share. 30 Sep 2022 365 77,726 (0%) 0% 46.5 16,983 Common Stock
Joel S. Marcus Director Sale of securities on an exchange or to another person at price $ 59.22 per share. 11 Aug 2022 10,000 44,233 (0%) 0% 59.2 592,200 Common Stock
Robert L. Van Nostrand Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Aug 2022 20,000 0 - - Stock Option (right to buy)
Robert L. Van Nostrand Director Sale of securities on an exchange or to another person at price $ 56.80 per share. 11 Aug 2022 1,500 9,043 (0%) 0% 56.8 85,200 Common Stock
Robert L. Van Nostrand Director Sale of securities on an exchange or to another person at price $ 57.15 per share. 11 Aug 2022 28,500 10,543 (0%) 0% 57.2 1,628,775 Common Stock
Robert L. Van Nostrand Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.05 per share. 11 Aug 2022 10,000 39,043 (0%) 0% 13.1 130,500 Common Stock
Robert L. Van Nostrand Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.45 per share. 11 Aug 2022 20,000 29,043 (0%) 0% 12.5 249,000 Common Stock
Robert L. Van Nostrand Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Aug 2022 10,000 10,000 - - Stock Option (right to buy)
Robert L. Van Nostrand Director Grant, award, or other acquisition of securities at price $ 57.08 per share. 30 Jun 2022 108 9,043 (0%) 0% 57.1 6,165 Common Stock
Rory B. Riggs Director Grant, award, or other acquisition of securities at price $ 57.08 per share. 30 Jun 2022 289 77,361 (0%) 0% 57.1 16,496 Common Stock
Joel S. Marcus Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 16,757 16,757 - - Stock Option (right to buy)
Robert L. Van Nostrand Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 16,757 16,757 - - Stock Option (right to buy)
Rory B. Riggs Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 16,757 16,757 - - Stock Option (right to buy)
Michael Rawlins Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 16,757 16,757 - - Stock Option (right to buy)
Eduardo Rene Salas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 16,757 16,757 - - Stock Option (right to buy)
Eduardo Rene Salas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Apr 2022 20,000 20,000 - - Stock Option (right to buy)
Mark Neumann EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 63.55 per share. 08 Apr 2022 17,476 114,211 (0%) 0% 63.6 1,110,600 Common Stock
Mark Neumann EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Apr 2022 86,348 0 - - Stock Option (right to buy)
Mark Neumann EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 65.14 per share. 08 Apr 2022 14,885 45,339 (0%) 0% 65.1 969,609 Common Stock
Mark Neumann EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 64.42 per share. 08 Apr 2022 53,987 60,224 (0%) 0% 64.4 3,477,843 Common Stock
Mark Neumann EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.73 per share. 08 Apr 2022 86,348 131,687 (0%) 0% 12.7 1,099,210 Common Stock
Robert L. Van Nostrand Director Grant, award, or other acquisition of securities at price $ 61.19 per share. 31 Mar 2022 126 8,935 (0%) 0% 61.2 7,710 Common Stock
Rory B. Riggs Director Grant, award, or other acquisition of securities at price $ 61.19 per share. 31 Mar 2022 257 77,072 (0%) 0% 61.2 15,726 Common Stock
Michael I. Halstead EVP and General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 22,034 22,034 - - Restricted Stock Units
Michael I. Halstead EVP and General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 17,916 17,916 - - Stock Option (right to buy)
Sharon Mates Director, Chairman, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 50,167 50,167 - - Stock Option (right to buy)
Sharon Mates Director, Chairman, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 61,696 61,696 - - Restricted Stock Units
Lawrence J. Hineline SVP of Finance CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 16,746 16,746 - - Restricted Stock Units
Lawrence J. Hineline SVP of Finance CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 13,616 13,616 - - Stock Option (right to buy)
Mark Neumann EVP, Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 17,916 17,916 - - Stock Option (right to buy)
Mark Neumann EVP, Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 22,034 22,034 - - Restricted Stock Units
Suresh K. Durgam Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 17,916 17,916 - - Stock Option (right to buy)
Suresh K. Durgam Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 22,034 22,034 - - Restricted Stock Units
Sharon Mates Director, Chairman, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Mar 2022 38,925 0 - - Stock Option (right to buy)
Sharon Mates Director, Chairman, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.84 per share. 09 Mar 2022 38,925 1,133,392 (1%) 0% 2.8 110,547 Common Stock
Joel S. Marcus Director Sale of securities on an exchange or to another person at price $ 52.89 per share. 07 Mar 2022 10,000 28,980 (0%) 0% 52.9 528,900 Common Stock
Joel S. Marcus Director Sale of securities on an exchange or to another person at price $ 54.52 per share. 07 Mar 2022 5,000 43,980 (0%) 0% 54.5 272,600 Common Stock
Joel S. Marcus Director Sale of securities on an exchange or to another person at price $ 52.25 per share. 07 Mar 2022 5,000 38,980 (0%) 0% 52.3 261,250 Common Stock
Suresh K. Durgam Chief Medical Officer Sale of securities on an exchange or to another person at price $ 55.52 per share. 02 Mar 2022 3,860 23,104 (0%) 0% 55.5 214,307 Common Stock
Suresh K. Durgam Chief Medical Officer Sale of securities on an exchange or to another person at price $ 56.98 per share. 02 Mar 2022 4,177 26,964 (0%) 0% 57.0 238,005 Common Stock
Michael I. Halstead EVP and General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2022 11,139 11,139 - - Restricted Stock Units
Michael I. Halstead EVP and General Counsel Sale of securities on an exchange or to another person at price $ 54.98 per share. 18 Feb 2022 4,550 0 (0%) 0% 55.0 250,159 Common Stock
Michael I. Halstead EVP and General Counsel Sale of securities on an exchange or to another person at price $ 55.69 per share. 18 Feb 2022 6,589 4,550 (0%) 0% 55.7 366,941 Common Stock
Michael I. Halstead EVP and General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2022 11,139 11,139 (0%) 0% - Common Stock
Sharon Mates Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 55.73 per share. 18 Feb 2022 15,180 1,107,134 (1%) 0% 55.7 845,981 Common Stock
Sharon Mates Director, Chairman, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2022 27,847 27,848 - - Restricted Stock Units
Sharon Mates Director, Chairman, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2022 27,847 1,122,314 (1%) 0% - Common Stock
Sharon Mates Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 54.98 per share. 18 Feb 2022 12,667 1,094,467 (1%) 0% 55.0 696,432 Common Stock
Lawrence J. Hineline SVP of Finance CFO Sale of securities on an exchange or to another person at price $ 55.72 per share. 18 Feb 2022 5,816 4,627 (0%) 0% 55.7 324,068 Common Stock
Lawrence J. Hineline SVP of Finance CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2022 10,443 10,443 - - Restricted Stock Units
Lawrence J. Hineline SVP of Finance CFO Sale of securities on an exchange or to another person at price $ 54.99 per share. 18 Feb 2022 4,627 0 (0%) 0% 55.0 254,439 Common Stock
Lawrence J. Hineline SVP of Finance CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2022 10,443 10,443 (0%) 0% - Common Stock
Mark Neumann EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2022 11,139 11,139 - - Restricted Stock Units
Mark Neumann EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 54.84 per share. 18 Feb 2022 4,607 45,339 (0%) 0% 54.8 252,648 Common Stock
Mark Neumann EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 55.60 per share. 18 Feb 2022 6,532 49,946 (0%) 0% 55.6 363,179 Common Stock
Mark Neumann EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2022 11,139 56,478 (0%) 0% - Common Stock
Suresh K. Durgam Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2022 8,354 31,458 (0%) 0% - Common Stock
Suresh K. Durgam Chief Medical Officer Sale of securities on an exchange or to another person at price $ 55.53 per share. 18 Feb 2022 2,820 28,638 (0%) 0% 55.5 156,595 Common Stock
Suresh K. Durgam Chief Medical Officer Sale of securities on an exchange or to another person at price $ 54.80 per share. 18 Feb 2022 1,357 27,281 (0%) 0% 54.8 74,364 Common Stock
Suresh K. Durgam Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2022 8,354 8,354 - - Restricted Stock Units
Suresh K. Durgam Chief Medical Officer Sale of securities on an exchange or to another person at price $ 42.03 per share. 18 Jan 2022 6,223 23,104 (0%) 0% 42.0 261,553 Common Stock
Michael I. Halstead EVP and General Counsel Sale of securities on an exchange or to another person at price $ 40.12 per share. 08 Jan 2022 4,380 0 (0%) 0% 40.1 175,726 Common Stock
Michael I. Halstead EVP and General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jan 2022 19,639 19,639 (0%) 0% - Common Stock
Michael I. Halstead EVP and General Counsel Sale of securities on an exchange or to another person at price $ 41.74 per share. 08 Jan 2022 2,504 17,135 (0%) 0% 41.7 104,517 Common Stock
Michael I. Halstead EVP and General Counsel Sale of securities on an exchange or to another person at price $ 40.81 per share. 08 Jan 2022 12,755 4,380 (0%) 0% 40.8 520,532 Common Stock
Michael I. Halstead EVP and General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jan 2022 19,639 0 - - Restricted Stock Units
Sharon Mates Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 41.72 per share. 08 Jan 2022 5,804 1,130,559 (1%) 0% 41.7 242,143 Common Stock
Sharon Mates Director, Chairman, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jan 2022 41,896 0 - - Restricted Stock Units
Sharon Mates Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 40.10 per share. 08 Jan 2022 8,954 1,094,467 (1%) 0% 40.1 359,055 Common Stock
Sharon Mates Director, Chairman, President & CEO Sale of securities on an exchange or to another person at price $ 40.80 per share. 08 Jan 2022 27,138 1,103,421 (1%) 0% 40.8 1,107,230 Common Stock
Sharon Mates Director, Chairman, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jan 2022 41,896 1,136,363 (1%) 0% - Common Stock
Lawrence J. Hineline SVP of Finance CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jan 2022 19,639 0 - - Restricted Stock Units
Lawrence J. Hineline SVP of Finance CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jan 2022 19,639 19,639 (0%) 0% - Common Stock
Lawrence J. Hineline SVP of Finance CFO Sale of securities on an exchange or to another person at price $ 41.61 per share. 08 Jan 2022 3,105 16,534 (0%) 0% 41.6 129,199 Common Stock
Lawrence J. Hineline SVP of Finance CFO Sale of securities on an exchange or to another person at price $ 40.77 per share. 08 Jan 2022 12,434 4,100 (0%) 0% 40.8 506,934 Common Stock
Lawrence J. Hineline SVP of Finance CFO Sale of securities on an exchange or to another person at price $ 40.07 per share. 08 Jan 2022 4,100 0 (0%) 0% 40.1 164,287 Common Stock
Mark Neumann EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 41.74 per share. 08 Jan 2022 2,761 63,526 (0%) 0% 41.7 115,244 Common Stock
Mark Neumann EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jan 2022 20,948 0 - - Restricted Stock Units
Mark Neumann EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 40.09 per share. 08 Jan 2022 4,252 45,339 (0%) 0% 40.1 170,463 Common Stock
Mark Neumann EVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 40.80 per share. 08 Jan 2022 13,935 49,591 (0%) 0% 40.8 568,548 Common Stock
Mark Neumann EVP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jan 2022 20,948 66,287 (0%) 0% - Common Stock
Suresh K. Durgam Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jan 2022 13,093 36,197 (0%) 0% - Common Stock
Suresh K. Durgam Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jan 2022 13,093 0 - - Restricted Stock Units
Suresh K. Durgam Chief Medical Officer Sale of securities on an exchange or to another person at price $ 39.83 per share. 08 Jan 2022 500 29,327 (0%) 0% 39.8 19,915 Common Stock
Suresh K. Durgam Chief Medical Officer Sale of securities on an exchange or to another person at price $ 40.63 per share. 08 Jan 2022 4,850 29,827 (0%) 0% 40.6 197,056 Common Stock
Suresh K. Durgam Chief Medical Officer Sale of securities on an exchange or to another person at price $ 41.48 per share. 08 Jan 2022 1,520 34,677 (0%) 0% 41.5 63,050 Common Stock
Michael I. Halstead EVP and General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Dec 2021 63,717 0 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters